Skip to main content
MEDINET Co., Ltd. logo

MEDINET Co., Ltd. — Investor Relations & Filings

Ticker · 2370 ISIN · JP3920990003 T Manufacturing
Open in API
Filings indexed 64 across all filing types
Latest filing 2024-05-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 2370

About MEDINET Co., Ltd.

https://www.medinet-inc.co.jp/english/

MEDINET Co., Ltd. is a Contract Development and Manufacturing Organization (CDMO) specializing in regenerative medicine and cell therapy. The company provides comprehensive, one-stop solutions across the entire value chain, from pre-clinical research and process development to manufacturing and commercial launch. Its services encompass technology transfer, quality control, and quality assurance for regenerative medical products, investigational products, and specified cell products. MEDINET operates an advanced cell processing facility (CPF) designed to comply with international standards such as GCTP, leveraging extensive experience since 1999 to support clients in developing and manufacturing their cellular therapies.

Recent filings

Filing Released Lang Actions
四半期報告書－第29期第2四半期(2024/01/01－2024/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the second quarter of the 29th fiscal period (2024-01-01 to 2024-03-31) for Medinet Co., Ltd. It contains detailed financial statements, management analysis (MDA), and business status updates, which are characteristic of an Interim/Quarterly Report (IR). Q2 2024
2024-05-14 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text contains the header "第１四半期報告書" (First Quarter Report) and specifies a fiscal period ("第29期第１四半期（自2023年10月１日 至2023年12月31日）"). It also references the Financial Instruments and Exchange Act ("金融商品取引法") and confirms the appropriateness of the filing's content by the representative director. This structure strongly indicates a comprehensive quarterly financial report, which aligns with the definition of an Interim / Quarterly Report (IR). The document length is very short (635 chars), but the content is the certification/confirmation *of* the report's contents, not just an announcement *about* the report's release, making it a component or summary of the formal filing itself, rather than a simple RPA/RNS announcement.
2024-02-13 Japanese
四半期報告書－第29期第1四半期(2023/10/01－2023/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the first quarter of the 29th fiscal period (2023-10-01 to 2023-12-31) for MEDINET Co., Ltd. It contains detailed financial statements (Balance Sheet, Income Statement) and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-02-13 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly states it is filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type, as they do not contain the actual financial statements themselves. FY 2023
2023-12-21 Japanese
内部統制報告書－第28期(2022/10/01－2023/09/30)
Governance Information Classification · 100% confidence The document is titled "内部統制報告書" (Internal Control Report) and explicitly references the legal basis as "金融商品取引法第24条の４の４第１項" (Financial Instruments and Exchange Act Article 24-4-4, Paragraph 1). It details the framework, scope, criteria (using the standard established by the Financial Accounting Standards Board), and the conclusion that internal controls over financial reporting are effective as of the fiscal year-end (September 30, 2023). This structure is characteristic of a formal internal control report filed under Japanese securities law, which is analogous to the Sarbanes-Oxley Section 404 reporting required in the US. Among the provided codes, 'AR' (Audit Report / Information) is the closest fit for a formal report detailing internal control assessment results, although 'CGR' (Governance Information) is also related. However, given the specific focus on '財務報告に係る内部統制' (Internal Control over Financial Reporting) and the formal structure, 'AR' is the most appropriate classification for this type of regulatory assurance/assessment document, distinct from a full annual report (10-K) or a general governance report.
2023-12-21 Japanese
有価証券報告書－第28期(2022/10/01－2023/09/30)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains comprehensive financial statements, management discussion, and corporate information for the fiscal year ending September 30, 2023. It is a formal regulatory filing submitted to the Kanto Local Finance Bureau. FY 2023
2023-12-21 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.